Bilaketaren emaitzak - Laura Van't Veer

Findu emaitzak
  1. 1
    Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays

    Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays nork Kathy S. Albain, Soonmyung Paik, Laura van’t Veer

    Argitaratua 2009
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    The MINDACT trial: The first prospective clinical validation of a genomic tool

    The MINDACT trial: The first prospective clinical validation of a genomic tool nork Fátima Cardoso, Martine Piccart, Laura Van't Veer, Emiel J. Rutgers

    Argitaratua 2007
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary

    Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary nork John Bridgewater, Ryan K. van Laar, Arno Floore, Laura van’t Veer

    Argitaratua 2008
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity

    Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity nork Denise M. Wolf, Marc E. Lenburg, Christina Yau, Aaron Boudreau, Laura van ‘t Veer

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma

    Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma nork Patti Curl, Igor Vujic, Laura van ‘t Veer, Susana Ortiz‐Urda, James G. Kahn

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein.

    TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. nork Guus Hateboer, H. T. Marc Timmers, AK Rustgi, Marc Billaud, Laura van ‘t Veer, René Bernards

    Argitaratua 1993
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    E2F-5, a New E2F Family Member That Interacts with p130 In Vivo

    E2F-5, a New E2F Family Member That Interacts with p130 In Vivo nork E. Marielle Hijmans, P. Mathijs Voorhoeve, Roderick L. Beijersbergen, Laura van ‘t Veer, René Bernards

    Argitaratua 1995
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability

    Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability nork Josien C.C. Scheepens, Laura van ‘t Veer, Laura J. Esserman, Jeffrey Belkora, Rita A. Mukhtar

    Argitaratua 2021
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance

    Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance nork Pavel Stejskal, Hani Goodarzi, Josef Srovnal, Marián Hajdúch, Laura van ‘t Veer, Mark Jesus M. Magbanua

    Argitaratua 2023
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian polycomb complex.

    Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian polycomb complex. nork Mark J. Alkema, Marieke Bronk, Els Verhoeven, Arie P. Otte, Laura van ‘t Veer, A Berns, Maarten van Lohuizen

    Argitaratua 1997
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature

    Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature nork Michael Knauer, Fátima Cardoso, Jelle Wesseling, Philippe L. Bédard, Sabine C. Linn, Emiel J. Rutgers, Laura van ‘t Veer

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis

    Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis nork Alexandra J. van den Broek, Marjanka K. Schmidt, Laura van ‘t Veer, Rob A.�E.�M. Tollenaar, Flora E. van Leeuwen

    Argitaratua 2015
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Comparison of prognostic gene expression signatures for breast cancer

    Comparison of prognostic gene expression signatures for breast cancer nork Benjamin Haibe‐Kains, Christine Desmedt, Fanny Piette, Marc Buyse, Fátima Cardoso, Laura van’t Veer, Martine Piccart, Gianluca Bontempi, Christos Sotiriou

    Argitaratua 2008
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Expression profiling predicts outcome in breast cancer

    Expression profiling predicts outcome in breast cancer nork Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver, Yudong D. He, Augustinus A. M. Hart, René Bernards, Stephen Friend

    Argitaratua 2002
    Testu osoa Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer

    Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer nork Rob Michalides, Alexander Griekspoor, Astrid Balkenende, Desirée Verwoerd, Lennert Janssen, Kees Jalink, Arno Floore, Arno Velds, Laura van 't Veer, Jacques Neefjes

    Argitaratua 2004
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    N-ras mutations in human cutaneous melanoma from sun-exposed body sites.

    N-ras mutations in human cutaneous melanoma from sun-exposed body sites. nork Laura van ‘t Veer, Boudewijn Burgering, Rogier Versteeg, A J Boot, D. J. Ruiter, Susanne Osanto, Peter I. Schrier, Johannes L. Bos

    Argitaratua 1989
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    A protocol for building and evaluating predictors of disease state based on microarray data

    A protocol for building and evaluating predictors of disease state based on microarray data nork Lodewyk F.A. Wessels, Marcel J. T. Reinders, A.A.M. Hart, Cor J. Veenman, H. Dai, Yudong D. He, Laura van ‘t Veer

    Argitaratua 2005
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients

    Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients nork James M. Ford, Sophie Adams, Taylor Sittler, Jeroen van den Akker, Salina Chan, Ofri Leitner, Lauren Ryan, Elad Gil, Laura van ’t Veer

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    A combined oncogenic pathway signature of<i>BRAF</i>,<i>KRAS</i>and<i>PI3KCA</i>mutation improves colorectal cancer classification and cetuximab treatment prediction

    A combined oncogenic pathway signature of<i>BRAF</i>,<i>KRAS</i>and<i>PI3KCA</i>mutation improves colorectal cancer classification and cetuximab treatment prediction nork Sun Tian, Iris Simón, Vı́ctor Moreno, Paul Roepman, Josep Tabernero, Mireille H.J. Snel, Laura van’t Veer, Ramón Salazar, René Bernards, Gabriel Capellà

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Additional prognostic value of the 70-gene signature (MammaPrint®) among breast cancer patients with 4–9 positive lymph nodes

    Additional prognostic value of the 70-gene signature (MammaPrint®) among breast cancer patients with 4–9 positive lymph nodes nork Mahasti Saghatchian, Stella Mook, Giancarlo Pruneri, Giuseppe Viale, Annuska M. Glas, Sylvie Guérin, Fátima Cardoso, Martine Piccart, Thomas Tursz, Suzette Delaloge, Laura van’t Veer

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: